Issue Areas
Artificial Intelligence
COVID-19
Health Equity, Diversity, & Inclusion
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
FDA Regulations
Medicaid Unwinding Resources
Resources
Member Resources
Fair-Market Value Calculator
Patient Experience Mapping
A Blueprint for Developing Patient-Centered Core Impact Sets (PC-CIS)
Meetings & Events
Newsroom
Letters & Comments
Research Briefs
Job Bank
Education
Real-World Evidence Classroom
Value Classroom
Patient-Focused Medical Product Development Series
Clinical Outcome Assessment Series
Health Literacy Series
Health Care Quality
Webinars
Blog
Membership
Our Members
Standards of Excellence
CAE Approved Provider
Become a Member
Accessibility Tools
Toggle navigation
letters & comments
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2020
02/19/2019
Read More
Institute for Clinical and Economic Review’s (ICER) Unsupported Price Increase Assessment
02/13/2019
Read More
Food and Drug Administration’s (FDA) Framework for a Real-World Evidence Program; Availability
02/07/2019
Read More
Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses
01/25/2019
Read More
Patient Engagement in Medical Device Clinical Trials Discussion Document
01/08/2019
Read More
Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs
12/31/2018
Read More
Centers for Medicare & Medicaid Services’ (CMS’) State Relief and Empowerment Waivers
12/24/2018
Read More
Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments
12/14/2018
Read More
CMS’s Accountable Care Organizations Pathways to Success
10/16/2018
Read More
« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next »